Download or read book Market Restraints in the Retail Drug Industry written by F. Marion Fletcher and published by University of Pennsylvania Press. This book was released on 2016-11-11 with total page 464 pages. Available in PDF, EPUB and Kindle. Book excerpt: Founded in 1921 as a separate Wharton department, the Industrial Research Unit has a long record of publication and research in the labor market, productivity, union relations, and business report fields. Major Industrial Research Unit studies as published as research projects are completed. This volume is Study no. 43.
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book Prescription and Non prescription Drugs written by Paul Ruschmann and published by Infobase Publishing. This book was released on 2007 with total page 121 pages. Available in PDF, EPUB and Kindle. Book excerpt: As people learned that some drugs on the market had deadly side effects, they prevailed on lawmakers to enact stronger regulations. Yet some also argue that increasing regulations has restricted access to low-cost and helpful medicines. This book offers readers the chance to form their own opinion on this issue.
Download or read book Handbook of Nonprescription Drugs written by Rosemary R. Berardi and published by American Pharmacists Association (APhA). This book was released on 2012 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thoroughly updated and revised, the Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care provides accessible information on nonprescription drug pharmacotherapy, nutritional supplements, medical foods, nondrug and preventive measures, and complementary and alternative therapies. The 17th edition helps students and practitioners develop problem-solving skills needed to assess and triage a pharmacy patients medical complaints. It provides Food and Drug Administration (FDA)approved dosing information and evidence-based research on the efficacy and safety of over-the-counter (OTC) and herbal medications. Key Features: 52 peer-reviewed chapters provide updated content on OTC medications and complementary therapies, prescription-to-OTC conversions, FDA revised or final rules, FDA safety and label warnings, therapeutic issues and controversies, treatment or prevention guidelines, OTC drug withdrawals from the market, and updated product tables and references.
Download or read book Nonprescription Drug Market written by Rector Press, Limited and published by . This book was released on 1994-08 with total page 400 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Nonprescription Drugs written by United States. General Accounting Office and published by . This book was released on 1992 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug Safety in Developing Countries written by Yaser Mohammed Al-Worafi and published by Academic Press. This book was released on 2020-06-03 with total page 656 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries. - Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues - Describes current achievements of drug safety practice in developing countries - Addresses the challenges of drug safety in developing countries - Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety
Download or read book Who s who in the Nonprescription Drug Industry written by Nonprescription Drug Manufacturers Association and published by . This book was released on 1990 with total page 190 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Nonprescription Product Therapeutics written by W. Steven Pray and published by Lippincott Williams & Wilkins. This book was released on 2006 with total page 974 pages. Available in PDF, EPUB and Kindle. Book excerpt: When it comes to helping customers make wiser and safer choices in their use of over-the-counter treatments, the pharmacist's best source of information is Nonprescription Product Therapeutics. This text emphasizes the pharmacist's role in triage--assessing the best nonprescription products for a client and knowing when medical conditions warrant a referral to another health professional. Organized by condition rather than by drug, the text is easy to consult, and complements a disease-based approach to therapeutics. Pharmacists will find useful information on ingredients, interactions, contraindications, and other essentials for helping customers choose appropriate nonprescription products. The Second Edition contains additional charts, drawings, illustrations, and tables. The book includes decision-making algorithms, case studies, patient counseling tips, and warnings on dangerous or life-threatening ingredients, actions, or situations. Another unique feature of this text is A Pharmacist's Journal--real-life reports from the front lines by an award-winning professor and researcher with over twenty years of experience in retail community pharmacy.
Download or read book The Prescription Drug Market written by Christine Huttin and published by North Holland. This book was released on 1992 with total page 316 pages. Available in PDF, EPUB and Kindle. Book excerpt: Presented in this volume are various contributions on the functioning and the dynamics of the prescription drug markets. Key issues such as switching drugs from prescription to over the counter (OTC); regulation versus competition; the search and patent terms; international comparisons of innovation processes; and patterns of consumption are all discussed in the book. At a time when many challenges are happening in the industry (e.g. stronger American and Japanese competition, regulatory changes, pressure for more cost containment, and decline of innovation), the book provides useful analysis of some of these changes.
Download or read book Drugs written by United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy and published by . This book was released on 1992 with total page 348 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Competitive Problems in the Drug Industry written by United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and published by . This book was released on 1967 with total page 284 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Zimmerman s Complete Guide to Nonprescription Drugs written by David R. Zimmerman and published by Gale Cengage. This book was released on 1993 with total page 1202 pages. Available in PDF, EPUB and Kindle. Book excerpt: Valuable resource to decipher the over-the-counter drug industry.
Download or read book Bottle of Lies written by Katherine Eban and published by HarperCollins. This book was released on 2020-06-23 with total page 512 pages. Available in PDF, EPUB and Kindle. Book excerpt: A NEW YORK TIMES BESTSELLER New York Times 100 Notable Books of 2019 New York Public Library Best Books of 2019 Kirkus Reviews Best Health and Science Books of 2019 Science Friday Best Books of 2019 New postscript by the author From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—The Jungle for pharmaceuticals Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings? A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
Download or read book Pain Management and the Opioid Epidemic written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-09-28 with total page 483 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Download or read book Inside the Drug Industry written by Bert Spilker and published by . This book was released on 1990 with total page 132 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Nonprescription Drugs written by Marcia Crosse and published by DIANE Publishing. This book was released on 2009-11 with total page 59 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the U.S., most nonprescription drugs are available over-the-counter in pharmacies and other stores. Experts have suggested that drug availability could be increased by establishing an additional class of nonprescription drugs that would be held behind the counter (BTC) but would require the intervention of a pharmacist before being dispensed; a similar class of drugs exists in many other countries. This is a report on: (1) arguments supporting and opposing a U.S. BTC drug class; (2) changes in drug availability in 5 countries and the impact of restricted nonprescription classes on availability; and (3) issues important to the establishment of a BTC drug class. The author studied 5 countries: Australia, Italy, the Netherlands, the U.K., and the U.S.
